Mangoceuticals, Inc. (NASDAQ: MGRX) is shaking up the men’s health market. The company’s $99/month all-inclusive injectable Testosterone Replacement Therapy (TRT) program, launched in mid-December, is already delivering impressive results. The program covers everything—doctor visits, consultations, lab work, and medication—offering men a simple and affordable way to optimize their hormones.
Explosive Growth and Lower Costs
Sales of MangoRx’s TRT program have surged 336% month over month. At the same time, the company cut its customer acquisition costs (CAC) by 54%. This rapid growth highlights the strong demand for convenient TRT options and the effectiveness of MangoRx’s marketing strategy.
Jacob Cohen, Mangoceuticals’ Founder and CEO, is thrilled with the results. “The demand for our injectable TRT product shows the value of our approach to men’s hormone health,” Cohen said. “By combining effective treatments with streamlined telehealth delivery, we’re making it easier for men to get the care they need.”
TRT Takes Center Stage
MangoRx is making TRT its top priority. The company is expanding its offerings to include both injectable and oral options, such as PRIME by MangoRx, powered by Kyzatrex®. With a clear focus on capturing more market share, MangoRx is positioning itself as a leader in this growing segment.
The global TRT market is expected to grow steadily, reaching $2.2 billion by 2025, according to The Business Research Company. An aging population, increased awareness of low testosterone symptoms, and advancements in TRT formulations are driving this growth. MangoRx is ready to capitalize on these trends.
Beyond TRT: A Broader Vision
While TRT remains the focus, MangoRx is thinking bigger. The company plans to expand its telehealth platform to offer a wider range of men’s health solutions. From erectile dysfunction and hair growth to weight management, MangoRx aims to address more wellness needs. This broader approach will strengthen its business and fuel long-term growth.
Safety and Compliance First
MangoRx prioritizes patient safety. Licensed healthcare providers prescribe all TRT products after thorough medical evaluations and lab testing. This ensures patients receive safe, effective, and personalized care.
About Mangoceuticals, Inc.
Mangoceuticals develops and delivers men’s health products through its secure telemedicine platform. The company offers treatments for erectile dysfunction, hair growth, hormone replacement, and weight management. Patients can easily request prescriptions, which are reviewed by licensed providers and discreetly shipped to their door.
For more information, visit www.MangoRx.com.
The Bottom Line
MangoRx’s $99/month TRT program is off to a strong start. With skyrocketing sales and lower costs, the company is proving its ability to meet growing demand. By focusing on TRT and expanding its telehealth platform, MangoRx is setting itself up for long-term success in the men’s health market.
The post MangoRx Sees Rapid Growth with $99/Month Injectable Testosterone Replacement Therapy Program appeared first on PRISM MarketView.
